Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 214(suppl 3): S110-S121, 2016 10 15.
Article in English | MEDLINE | ID: mdl-27402779

ABSTRACT

BACKGROUND: Kenema Government Hospital (KGH) has developed an advanced clinical and laboratory research capacity to manage the threat of Lassa fever, a viral hemorrhagic fever (VHF). The 2013-2016 Ebola virus (EBOV) disease (EVD) outbreak is the first to have occurred in an area close to a facility with established clinical and laboratory capacity for study of VHFs. METHODS: Because of its proximity to the epicenter of the EVD outbreak, which began in Guinea in March 2014, the KGH Lassa fever Team mobilized to establish EBOV surveillance and diagnostic capabilities. RESULTS: Augustine Goba, director of the KGH Lassa laboratory, diagnosed the first documented case of EVD in Sierra Leone, on 25 May 2014. Thereafter, KGH received and cared for numbers of patients with EVD that quickly overwhelmed the capacity for safe management. Numerous healthcare workers contracted and lost their lives to EVD. The vast majority of subsequent EVD cases in West Africa can be traced back to a single transmission chain that includes this first diagnosed case. CONCLUSIONS: Responding to the challenges of confronting 2 hemorrhagic fever viruses will require continued investments in the development of countermeasures (vaccines, therapeutic agents, and diagnostic assays), infrastructure, and human resources.


Subject(s)
Disease Outbreaks , Ebolavirus/isolation & purification , Genome, Viral/genetics , Hemorrhagic Fever, Ebola/epidemiology , Lassa Fever/epidemiology , Lassa virus/isolation & purification , Adolescent , Adult , Africa, Western/epidemiology , Child , Child, Preschool , Ebolavirus/genetics , Epidemiological Monitoring , Female , Genomics , Guinea/epidemiology , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/transmission , Hemorrhagic Fever, Ebola/virology , Humans , Lassa Fever/diagnosis , Lassa Fever/transmission , Lassa Fever/virology , Lassa virus/genetics , Male , Middle Aged , Sequence Analysis, DNA , Sierra Leone/epidemiology , Young Adult
2.
N Engl J Med ; 371(22): 2092-100, 2014 Nov 27.
Article in English | MEDLINE | ID: mdl-25353969

ABSTRACT

BACKGROUND: Limited clinical and laboratory data are available on patients with Ebola virus disease (EVD). The Kenema Government Hospital in Sierra Leone, which had an existing infrastructure for research regarding viral hemorrhagic fever, has received and cared for patients with EVD since the beginning of the outbreak in Sierra Leone in May 2014. METHODS: We reviewed available epidemiologic, clinical, and laboratory records of patients in whom EVD was diagnosed between May 25 and June 18, 2014. We used quantitative reverse-transcriptase-polymerase-chain-reaction assays to assess the load of Ebola virus (EBOV, Zaire species) in a subgroup of patients. RESULTS: Of 106 patients in whom EVD was diagnosed, 87 had a known outcome, and 44 had detailed clinical information available. The incubation period was estimated to be 6 to 12 days, and the case fatality rate was 74%. Common findings at presentation included fever (in 89% of the patients), headache (in 80%), weakness (in 66%), dizziness (in 60%), diarrhea (in 51%), abdominal pain (in 40%), and vomiting (in 34%). Clinical and laboratory factors at presentation that were associated with a fatal outcome included fever, weakness, dizziness, diarrhea, and elevated levels of blood urea nitrogen, aspartate aminotransferase, and creatinine. Exploratory analyses indicated that patients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (57% vs. 94%, P=0.03), and patients presenting with fewer than 100,000 EBOV copies per milliliter had a lower case fatality rate than those with 10 million EBOV copies per milliliter or more (33% vs. 94%, P=0.003). Bleeding occurred in only 1 patient. CONCLUSIONS: The incubation period and case fatality rate among patients with EVD in Sierra Leone are similar to those observed elsewhere in the 2014 outbreak and in previous outbreaks. Although bleeding was an infrequent finding, diarrhea and other gastrointestinal manifestations were common. (Funded by the National Institutes of Health and others.).


Subject(s)
Ebolavirus/genetics , Epidemics , Hemorrhagic Fever, Ebola/epidemiology , Abdominal Pain , Adult , Animals , Diarrhea , Ebolavirus/isolation & purification , Female , Fever , Hemorrhagic Fever, Ebola/complications , Hemorrhagic Fever, Ebola/therapy , Hemorrhagic Fever, Ebola/virology , Humans , Male , Middle Aged , Mortality , Reverse Transcriptase Polymerase Chain Reaction , Sierra Leone/epidemiology , Viral Load , Vomiting
3.
Science ; 345(6202): 1369-72, 2014 Sep 12.
Article in English | MEDLINE | ID: mdl-25214632

ABSTRACT

In its largest outbreak, Ebola virus disease is spreading through Guinea, Liberia, Sierra Leone, and Nigeria. We sequenced 99 Ebola virus genomes from 78 patients in Sierra Leone to ~2000× coverage. We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Because many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response.


Subject(s)
Disease Outbreaks , Ebolavirus/genetics , Epidemiological Monitoring , Hemorrhagic Fever, Ebola/transmission , Hemorrhagic Fever, Ebola/virology , Base Sequence , Ebolavirus/isolation & purification , Genetic Variation , Genome, Viral/genetics , Genomics/methods , Hemorrhagic Fever, Ebola/epidemiology , Humans , Mutation , Sequence Analysis, DNA , Sierra Leone/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...